M&A Executive Search provided an interim laboratory director and molecular diagnostics leader to a high-complexity clinical testing laboratory to address a critical laboratory leadership, assay development, and regulatory compliance need.
The engagement focused on overseeing molecular assay research and development, validation of innovative diagnostic tests, CLIA and CAP compliance, laboratory quality systems, reimbursement strategy, and regulatory pathway planning. Working as an embedded member of the laboratory leadership team, the interim executive provided expertise in molecular oncology, hereditary genetics, pharmacogenomics, laboratory operations, and commercialization of advanced diagnostic technologies. The assignment delivered experienced scientific and operational leadership, enabling the organization to accelerate test development, strengthen regulatory compliance, support laboratory growth, and advance innovative molecular diagnostics from development through clinical implementation.
